Lykos Therapeutics fka MAPS PBC
5 known investors
Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder. The company applies decades of evidence-based research to create new therapeutic approaches for patients with unmet mental healthcare needs.
Investors · 5
Frequently asked questions
- What does Lykos Therapeutics fka MAPS PBC do?
- Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder. The company applies decades of evidence-based research to create new therapeutic approaches for patients with unmet mental healthcare needs.
- Who are Lykos Therapeutics fka MAPS PBC's investors?
- Lykos Therapeutics fka MAPS PBC's investors include JourneyOne Ventures, Lauder Partners, Leafy Tunnel, Solari Capital, WGD Capital, L.P..